Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jeffrey Yung-Chuan Chao"'
Autor:
Jeffrey Yung-chuan Chao, Hsin-Chuan Chang, Jeng-Kai Jiang, Chih-Yung Yang, Fang-Hsin Chen, Yo-Liang Lai, Wen-Jen Lin, Chia-Yang Li, Shu-Chi Wang, Muh-Hwa Yang, Yu-Feng Lin, Wei-Chung Cheng
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss , Pp 3922-3929 (2021)
Colorectal cancer (CRC) results from the uncontrolled growth of cells in the colon, rectum, or appendix. The 5-year relative survival rate for patients with CRC is 65% and is correlated with the stage at diagnosis (being 91% for stage I at diagnosis
Externí odkaz:
https://doaj.org/article/418360957aca483988173b82ae0d0b88
Autor:
Fang-Hsin Chen, Wen Jen Lin, Muh Hwa Yang, Jeffrey Yung chuan Chao, Jeng Kai Jiang, Chia Yang Li, Yu Feng Lin, Shu Chi Wang, Hsin Chuan Chang, Wei-Chung Cheng, Yo Liang Lai, Chih Yung Yang
Publikováno v:
Computational and Structural Biotechnology Journal
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 3922-3929 (2021)
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 3922-3929 (2021)
Graphical abstract
Colorectal cancer (CRC) results from the uncontrolled growth of cells in the colon, rectum, or appendix. The 5-year relative survival rate for patients with CRC is 65% and is correlated with the stage at diagnosis (being 91% f
Colorectal cancer (CRC) results from the uncontrolled growth of cells in the colon, rectum, or appendix. The 5-year relative survival rate for patients with CRC is 65% and is correlated with the stage at diagnosis (being 91% f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a83012efcd9bbac03267e2e35e46dd49
http://europepmc.org/articles/PMC8280477
http://europepmc.org/articles/PMC8280477
Autor:
Ching-Wen Huang, Jaw-Yuan Wang, Chou-Pin Chen, Po-Li Wei, Huang-Ming Hu, Wen-Hung Hsu, Hsiang-Yao Shih, Ming-Yii Huang, Chiao-Yun Chen, Chao-Hung Kuo, Chou-Chen Chen, Tzu-Wei Chiang, Jeffrey Yung-Chuan Chao, You-Hsin Chiu, Cheng Tiong, Pao-Ying Lin, Long-Sheng Lu, Ching-Huei Kung, Wei-Che Yu, Yu-Shan Wu
Publikováno v:
Journal of Clinical Oncology. 40:3603-3603
3603 Background: PEP503 (aka NBTXR3) is a novel radio-enhancer composed of functionalized hafnium oxide nanoparticles that increases the energy deposition of radiotherapy. A phase 3 study in soft tissue sarcoma patients has significantly increased pC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a75ae48b0223ca13459f9ad8baf7b35e
https://doi.org/10.1200/jco.2022.40.16_suppl.3603
https://doi.org/10.1200/jco.2022.40.16_suppl.3603
Autor:
Hsiang-Yao Shih, Jaw-Yuan Wang, You-Hsin Chiu, Wen-Hung Hsu, Ming-Yii Huang, Jeffrey Yung-Chuan Chao, Chou-Pin Chen, Ching-Wen Huang, Huang-Ming Hu, Chiao-Yun Chen
Publikováno v:
Journal of Clinical Oncology. 39:66-66
66 Background: PEP503 (as known as NBTXR3) is a novel radio-enhancer composed of functionalized hafnium oxide nanoparticles for a higher energy deposit by radiotherapy comparing to radiotherapy alone without it. A prior phase 3 study for soft tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c63e3c65d71099b009f15fa71db8bd2a
https://doi.org/10.1200/jco.2021.39.3_suppl.66
https://doi.org/10.1200/jco.2021.39.3_suppl.66
Autor:
Chen-Yang Chen, Hsei-Wei Wang, Cheng-Wen Wu, Cheng-Chung Cheng, Tse-Shun Huang, Ting-Yu Chang, I-Fang Chung, Shao-Chuan Wang, Wei-Chung Cheng, Hsing-Jen Sun, Jeffrey Yung-Chuan Chao, Cheng-Fong Tsai
Publikováno v:
Nucleic Acids Research
We previously presented YM500, which is an integrated database for miRNA quantification, isomiR identification, arm switching discovery and novel miRNA prediction from 468 human smRNA-seq datasets. Here in this updated YM500v2 database (http://ngs.ym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cdf75083bd2b48ea49c36c206d1a1a8
https://doi.org/10.1093/nar/gku1156
https://doi.org/10.1093/nar/gku1156
Autor:
Feng-Fan Chiang, Chen-Fa Chang, Jeffrey Yung-Chuan Chao, Hui-Ling Yeh, Jing-Chin Lin, Hwei-Ming Wang, Jia-Fu Lin
Publikováno v:
Journal of the Chinese Medical Association, Vol 77, Iss 3, Pp 128-132 (2014)
Background We conducted a Phase II study of biweekly oxaliplatin plus oral tegafur-uracil in the preoperative chemoradiotherapy (CRT) for locally advanced resectable mid-to-lower rectal cancer in our hospital, to evaluate the feasibility of this drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc7e106f12f01a18ebd36f5a6b6a839b